TECObiosciences
 
TECObiosciences, part of the Swiss-based TECOmedical group, is specialized on consultancy and support of the biopharmaceutical and diagnostic industry in the field of Research & Development, Manufacturing, Pre-clinical and Clinical Development, Regulatory Affairs and Business Development. TECObiosciences provides a strong understanding of QC and QA requirements for Biotech Product Development including quality by design approaches, release of drug substance and product as well as significant experience in the communication with Health Authorities. TECOmedical Group is a leading provider of in-vitro speciality test systems in the areas of medical and veterinary diagnostic, biosafety and environmental testing. New test systems are developed and evaluated in collaboration with opinion leaders or as service to pharma, CRO and research organisations.


Staff Expertise
  • Dr. Nadja Prang has over 15 years’ experience in the development of protein based therapeutics. After she received her PhD degree in immunology and virology she worked over 5 years in Contract Research Laboratory in Munich developing bioassays for the pharmaceutical industry before she joined Amgen/Micromet, as Head of Bioanalytical Development and QC in 2002. In 2005 she became Director of Global Bioanalytical Development of Serono in Rome and was appointed Head of Biotech Product Development for Oncology & Emerging Therapies in Merck-Serono in 2007. End of 2008 she joined LFB SA in Paris as Program Director for Monoclonal Antibodies. Today she is working as Chief Scientific Officer for TECObiosciences Gmbh.


Key facilities and infrastructure
  • TECObiosciences GmbH is part of the TECOmedical AG Group in Switzerland a diagnostic development and distributing organization with own diagnostic development facilities in Rheinbach, Germany.
  • TECO exploits a fully equipped preclinical imaging labs
  • Bioassay development will be facilitated in the biology labs


Previous involvement in Research and Training Programmes
  • TECObiosciences GmbH is part of the TECOmedical AG Group in Switzerland a diagnostic development and distributing organization with own diagnostic development facilities in Rheinbach, Germany.
  • TECO exploits a fully equipped preclinical imaging labs
  • Bioassay development will be facilitated in the biology labs


Current Involvement in Research and Training Programmes
  • Participant of the ZIM Cooperation Network Implants, Transplants and Bone Replacement, Bavaria, Germany (ZIM-Kooperationsnetzwerk Implantate, Transplantate und Knochenersatzmaterial
  • 2014 - 2018: EU Marie Curie RISE project, PRISAR


Publications
  • Joel Richard & Nadja S. Prang; IDrugs: the investigational drugs journal 08/2010; 13(8): 550-8.
  • Patrick A Baeuerle et al.; Leukemia research 11/2008; 33(3):465-73 DOI: 10.1016
  • Christian Brandl et al.; Cancer Immunology and Immunotherapy 11/2007; 56(10):1551-63. DOI: 10.1007
  • Ingo Mecklenburg et al.; Journal of Immunological Methods 07/2007; 323(2):180-93. DOI: 10.1016
  • Ralf Oberneder et al.; European Journal of Cancer. 11/2006; 42(15):2530-8. DOI:10.1016


Overview of all participants ...